Explore
Upload

DocSlides is a free service to upload presentations and documents.

Upload Now

Search Results for 'Tdf Taf'

Tdf Taf published presentations and documents on DocSlides.

ART Resistance and Second Line Regimens

ART Resistance and Second Line Regimens

  • calandra-battersby
  • 0 Slides

Learning Objectives. Understand when to switch to...

Review of Non-Daily PrEP Clinical Research and Experience

Review of Non-Daily PrEP Clinical Research and Experience

  • mitsue-stanley
  • 0 Slides

Robert M. Grant, M.D., M.P.H. .. IAS 2017, July 2...

Roy M. Gulick, MD, MPH Gladys and Roland Harriman Professor of Medicine

Roy M. Gulick, MD, MPH Gladys and Roland Harriman Professor of Medicine

  • luanne-stotts
  • 0 Slides

Chief, Division of Infectious Diseases. Weill Med...

ART for Prevention… What Happens Next?

ART for Prevention… What Happens Next?

  • briana-ranney
  • 0 Slides

Myron S. Cohen, MD. Yeargan-Bate Eminent Professo...

Characteristics and Oral

Characteristics and Oral

  • lois-ondreau
  • 0 Slides

PrEP. Adherence in the TDF2 Open-Label Extension...

Adaptive non-inferiority

Adaptive non-inferiority

  • cheryl-pisano
  • 0 Slides

margins under observable non-constancy. Brett Han...

ART in Resource-limited settings :

ART in Resource-limited settings :

  • liane-varnes
  • 0 Slides

Progress and Challenges. Dr. B. B. . Rewari. MD,...

ADOLESCENT PrEP STUDIES

ADOLESCENT PrEP STUDIES

  • min-jolicoeur
  • 0 Slides

. . Shorai. . Mukaka. , . MBchB. ...

Generic treatments for HIV, HBV, HCV, TB could be mass produced for <$90 per patient

Generic treatments for HIV, HBV, HCV, TB could be mass produced for <$90 per patient

  • min-jolicoeur
  • 0 Slides

Dr Dzintars Gotham MBBS BSc(Hons). on behalf of. ...

Issues Affecting ART Success: Adherence, ARV Toxicity, Drug Interactions

Issues Affecting ART Success: Adherence, ARV Toxicity, Drug Interactions

  • pamella-moone
  • 0 Slides

Guidelines for the Use of Antiretroviral Agents i...

Second-Generation HIV-1 Maturation Inhibitor BMS-955176: Antiviral Activity and Safety with Atazan

Second-Generation HIV-1 Maturation Inhibitor BMS-955176: Antiviral Activity and Safety with Atazan

  • sherrill-nordquist
  • 0 Slides

± . Ritonavir. Carey Hwang. ,. 1. Dirk Schürma...

Duke Energy Carolinas ATC Calculation Process

Duke Energy Carolinas ATC Calculation Process

  • stefany-barnette
  • 0 Slides

ATC Training. December 15. th. , 2011. Agenda. Ob...

Tenofovir nephrotoxicity in resource limited setting of Western India : Higher rate of renal functi

Tenofovir nephrotoxicity in resource limited setting of Western India : Higher rate of renal functi

  • conchita-marotz
  • 0 Slides

A.Dravid. 1. ,A.Sadre. 2. ,S.Dhande. 1. , A.Borka...

The Role of Pre-Exposure Prophylaxis (

The Role of Pre-Exposure Prophylaxis (

  • tatyana-admore
  • 0 Slides

PrEP. ) for the Prevention of HIV. Sarah . Kemink...

Track B Workshop Controversies in the Management of HIV-positive Adults:

Track B Workshop Controversies in the Management of HIV-positive Adults:

  • natalia-silvester
  • 0 Slides

A Case-Based Approach. Sasisopin Kiertiburanakul,...

The Role of Pre-Exposure Prophylaxis (

The Role of Pre-Exposure Prophylaxis (

  • olivia-moreira
  • 0 Slides

PrEP. ) for the Prevention of HIV. Sarah . Kemink...

Missing formulations for paediatric HIV treatment and the Dakar Call for

Missing formulations for paediatric HIV treatment and the Dakar Call for

  • trish-goza
  • 0 Slides

Action. Improving Access to Optimized Treatment ....

Module 1: INTRODUCTION TO ORAL

Module 1: INTRODUCTION TO ORAL

  • pamella-moone
  • 0 Slides

PrEP. Version. : December . 2018. Outline of tra...

Essentials for Optimal Care of HIV Patients

Essentials for Optimal Care of HIV Patients

  • marina-yarberry
  • 0 Slides

Evidence-Based Approaches. Simply Speaking. ®. ...

Donna E. Sweet, MD, AAHIVS, MACP

Donna E. Sweet, MD, AAHIVS, MACP

  • pasty-toler
  • 0 Slides

Professor of Medicine. The University of Kansas S...

Modifying Therapy in the Treatment-experienced Patient:

Modifying Therapy in the Treatment-experienced Patient:

  • yoshiko-marsland
  • 0 Slides

When should it be done?. Professor of Medicine. U...

Highlights for clinical

Highlights for clinical

  • pasty-toler
  • 0 Slides

. practice. HIV. International Congress of Drug ...

Antiretroviral Therapy (ART)

Antiretroviral Therapy (ART)

  • alexa-scheidler
  • 0 Slides

Dr. S . Ntshalintshali. Ngwelezana. hospital. N...

Florida AIDS Drug Assistance

Florida AIDS Drug Assistance

  • natalia-silvester
  • 0 Slides

Program. Improving Health. . . Promoting Wellness...

Comparison of PI vs PI ATV vs ATV/r BMS 089

Comparison of PI vs PI ATV vs ATV/r BMS 089

  • phoebe-click
  • 0 Slides

LPV/r mono vs LPV/r ZDV/3TC MONARK. LPV/r QD v...

Switch to NNRTI Switch to DOR/3TC/TDF

Switch to NNRTI Switch to DOR/3TC/TDF

  • ellena-manuel
  • 0 Slides

DRIVE-SHIFT. . Study. . Design. Endpoints. Prim...

2013 Antimicrobial Update

2013 Antimicrobial Update

  • marina-yarberry
  • 0 Slides

Oklahoma ACP Chapter . October 18, 2013. Michelle...

Joseph J. Eron Jr, MD

Joseph J. Eron Jr, MD

  • lois-ondreau
  • 38 Slides

Joseph J. Eron Jr, MD Professor of Medicine Unive...

PrEP and Key populations:

PrEP and Key populations:

  • lindy-dunigan
  • 11 Slides

PrEP and Key populations: WHO guidelines &...

Clinical M anagement

Clinical M anagement

  • natalia-silvester
  • 8 Slides

Clinical M anagement Module 4 (e) Pregnancy a...

PrEP to Prevent HIV and Promote Sexual Health

PrEP to Prevent HIV and Promote Sexual Health

  • cheryl-pisano
  • 35 Slides

PrEP to Prevent HIV and Promote Sexual Health www...

Florida AIDS Drug Assistance

Florida AIDS Drug Assistance

  • yoshiko-marsland
  • 0 Slides

Program. Improving Health. . . Promoting Wellness...

Comparison of INSTI vs EFV

Comparison of INSTI vs EFV

  • mediumgeneral
  • 12 Slides

STARTMRK. GS-US-236-0102 . SINGLE. Walmsley. S. N...

Towards ending the AIDS Epidemic: Progress and Evidence

Towards ending the AIDS Epidemic: Progress and Evidence

  • shoulderheinz
  • 25 Slides

Willard . Tinago. , . PhD. HIV . Molecular Researc...

The Eras of the HIV Epidemic

The Eras of the HIV Epidemic

  • relylancome
  • 28 Slides

1981-1986. 1987-1995. 1996-2005. 2006-2011. 2012+....

Issues Affecting ART Success: Adherence, ARV Toxicity, Drug Interactions

Issues Affecting ART Success: Adherence, ARV Toxicity, Drug Interactions

  • genesantander
  • 53 Slides

Guidelines for the Use of Antiretroviral Agents in...

16b21718196brt7118520b6415191234567b2tn116fnr

16b21718196brt7118520b6415191234567b2tn116fnr

  • daisy
  • 10 Slides

123453467b646tntb7t1175t423br18t573b515115b3 11815...

Clinical considerations for the

Clinical considerations for the

  • helene
  • 21 Slides

introduction . of . DTG. Nandita Sugandhi. ICAP at...

MMM Prof. Mirjana Menkovska

MMM Prof. Mirjana Menkovska

  • luna
  • 52 Slides

, . Ss.Cyril. and Methodius University, Skopje, M...

What’s New & Next in

What’s New & Next in

  • badra
  • 33 Slides

HIV Prevention . Mitchell Warren. July 2021. Outli...

Copyright © 2024 DocSlides. All Rights Reserved